| Molecular Weight: | 350.44 |
| Formula: | C19H18N4OS |
| Purity: | ≥ 98% |
| CAS#: | 315703-52-7 |
| Solubility: | DMSO up to 100mM |
| Chemical Name: | N-(4-Ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-thiazolamine |
| Storage: | Powder:4oC 1 year. DMSO:4oC3 month;-20oC 1 year. |
Biological Activity:
JK184 is a potent and cell-permeable inhibitor of hedgehog (Hh) signaling downstream of Smo, identified by a cell-based Hh pathway reporter screening. JK184 was found to inhibit Adh7 (IC50~210 nM), the class IV alcohol dehydrogenase as well as act as a microtubule depolymerizing agent in vitro. JK184 inhibits Hh agonit-induced Gli transcriptional activity (IC50~30 nM) as well as Gli1 and Ptc1 mRNA expression in a dose-dependent manner in 10T1/2 cells. It shows antiproliferative activity in a range of cancer cell lines (IC50~ 3 - 21 nM), and inhibits the growth of two xenografted tumors in mice in vivo.
How to Use:
- In vitro:JK184 was suggested to use at 1-5 µM concentration in vitro and in the cellular assays.
- In vivo:JK184 was dosed orally 0.2 mg/mouse once per day.
Reference:
- 1. Lee J, et al. A small-molecule antagonist of the hedgehog signaling pathway. (2007)Chembiochem 8(16):1916-9.
- 2. Cupido T, et al. The imidazopyridine derivative JK184 reveals dual roles for microtubules in Hedgehog signaling. (2009)Angew Chem Int Ed Engl. 48(13):2321-4.
JK184_spec.pdf- JK184_MSDS.pdf
Products are for research use only. Not for human use.
Xcess Biosciences，Inc.（XcessBio）由一群来自学术界和制药/生物技术行业的顶尖科学家于2008年成立，他们在药物化学，生物化学，分子和细胞生物学领域拥有丰富的专业知识。结合我们的合作者和顾问网络，我们致力于开发高质量的产品并提供最佳的服务，以满足生物医学研究中未满足的需求。
XcessBio的总部位于加利福尼亚州圣地亚哥，在最先进的研发设施中运营，设有化学合成实验室，分子和细胞生物学实验室以及分析质量控制实验室。
XcessBio一直为美国许多顶级制药，生物技术和试剂公司提供CRO服务和OEM产品，现在，我们将最好的产品和服务直接扩展到整个生命科学界。
暂无问答
本网站将在规定时间内给予删除等相关处理。
